Related Experiment Video
Updated: Feb 20, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
Probable Lyme carditis in pacemaker candidates with atrioventricular block: Preliminary results from northern Serbia
Dragana Gazibara1, Verica Simin2, Ivana Bogdan2
1Medical Faculty of Novi Sad, University of Novi Sad, Novi Sad, Serbia; Department of Quality Control, Pasteur Institute Novi Sad, Novi Sad, Serbia.
Insights
Approximately 10% of pacemaker candidates in Serbia had probable Lyme carditis. This suggests Lyme disease may be an underdiagnosed cause of cardiac conduction disorders in endemic areas.
Area of Science:
- Cardiology
- Infectious Diseases
- Epidemiology
Background:
- Cardiac conduction disorders requiring pacemaker implantation are common in elderly populations.
- Lyme carditis, a manifestation of Lyme disease, can cause significant cardiac conduction abnormalities.
- The prevalence of Lyme carditis as a cause for pacemaker implantation is not well-established in endemic regions like northern Serbia.
Purpose of the Study:
- To determine the proportion of patients with new cardiac conduction disorders needing pacemakers who exhibit serological evidence of probable Lyme carditis.
- To assess the utility of serological testing for Lyme disease in patients undergoing pacemaker implantation for conduction abnormalities.
Main Methods:
- Adults with new conduction disorders requiring permanent pacing were enrolled in northern Serbia.
- Serum samples were collected at baseline and 4-week follow-up for anti-Borrelia IgG testing using a two-tier ELISA and immunoblot algorithm.
- Probable Lyme carditis was defined by seroconversion or stable/rising IgG titers.
Main Results:
- Out of 74 participants completing follow-up, 8 (10.8%) showed serological patterns consistent with probable Lyme carditis.
- Third-degree atrioventricular block was the most common conduction disorder (56.8%).
- Seropositive patients were older, and higher IgG titers were observed in men at 4 weeks; no recent tick bite or erythema migrans was reported.
Conclusions:
- About 10% of pacemaker candidates in this endemic region had probable Lyme carditis.
- Utilizing paired serology for Lyme disease in evaluating high-grade conduction disorders may enhance etiological diagnosis and guide patient management.
Objectives:
This study aimed to estimate the proportion of patients with newly diagnosed cardiac conduction disorders requiring pacemaker implantation who have serological findings consistent with probable Lyme carditis in endemic northern Serbia.
Methods:
Adults presenting with new conduction disorders and scheduled for permanent pacing were enrolled and provided serum at baseline and 4-week follow-up. Anti-Borrelia immunoglobulin (Ig)G was assessed using a two-tier algorithm (enzyme-linked immunosorbent assay screening, immunoblot confirmation). Probable Lyme carditis was defined as IgG seroconversion or stable/rising titers; no Lyme carditis was defined as persistent seronegativity or declining titers.
Results:
Of 80 enrolled patients, 74 completed follow-up (92.5%; mean age 71.6 years; 68.9% male). Third-degree atrioventricular block was most frequent (56.8%). Probable Lyme carditis was identified in eight of 74 (10.8%) patients. Of 14 patients who were enzyme-linked immunosorbent assay-reactive/borderline, six (42.9%) were immunoblot-negative. Seropositive patients were older (age 76.3 vs 71.1 years); titers were higher in men at 4 weeks. IgG positivity was associated with suspected Lyme carditis (relative risk 6.8 at baseline; 16.2 at 4 weeks). No participant reported a recent tick bite or erythema migrans.
Conclusion:
Approximately one in 10 pacemaker candidates showed serological patterns compatible with probable Lyme carditis. Incorporating two-tier paired serology into evaluation of high-grade conduction disorders in endemic settings may improve etiologic diagnosis and inform management.
More Related Videos
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis III: Medical Management
Endocarditis I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Endocarditis III: Medical Management

